BACKGROUND: Discontinuation of daily oral pre-exposure prophylaxis (PrEP) is frequent among adolescent girls and young women (AGYW) in African settings. We explored factors influencing early PrEP discontinuation and persistence among Kenyan AGYW who accepted PrEP within a programmatic setting. METHODS: We conducted in-depth interviews with AGYW (aged 15-24 years) who accepted PrEP from 4 maternal child health (MCH) and family planning (FP) clinics. AGYW were identified by nurses at routine clinic visits and purposively sampled based on 4 categories: (1) accepted PrEP pills, but never initiated PrEP use (eg, never swallowed PrEP pills), (2) discontinued PrEP <1 month after initiation, (3) discontinued PrEP within 1-3 months, and (4) persisted with PrEP use >3 months. Informed by the Stages of Change Model, thematic analysis characterized key influences on PrEP discontinuation/persistence. RESULTS: We conducted 93 in-depth interviews with AGYW who accepted pills. Median age was 22 years, 71% were married; 89% were from MCH, and 11% were from FP clinics. Early PrEP use was positively influenced by encouragement from close confidants and effective concealment of PrEP pill-taking when necessary to avoid stigma or negative reactions from partners. Pregnancy helped conceal PrEP use because pill-taking is normalized during pregnancy, but concealment became more difficult postpartum. AGYW found keeping up with daily PrEP pill-taking challenging, and many noted only episodic periods of the HIV risk. Frequently testing HIV-negative reassured AGYW that PrEP was working and motivated persistence. DISCUSSION: As PrEP programs scale-up in MCH/FP, it is increasingly important to enhance protection-effective PrEP use through approaches tailored to AGYW, with special considerations during pregnancy and postpartum.
BACKGROUND: Discontinuation of daily oral pre-exposure prophylaxis (PrEP) is frequent among adolescent girls and young women (AGYW) in African settings. We explored factors influencing early PrEP discontinuation and persistence among Kenyan AGYW who accepted PrEP within a programmatic setting. METHODS: We conducted in-depth interviews with AGYW (aged 15-24 years) who accepted PrEP from 4 maternal child health (MCH) and family planning (FP) clinics. AGYW were identified by nurses at routine clinic visits and purposively sampled based on 4 categories: (1) accepted PrEP pills, but never initiated PrEP use (eg, never swallowed PrEP pills), (2) discontinued PrEP <1 month after initiation, (3) discontinued PrEP within 1-3 months, and (4) persisted with PrEP use >3 months. Informed by the Stages of Change Model, thematic analysis characterized key influences on PrEP discontinuation/persistence. RESULTS: We conducted 93 in-depth interviews with AGYW who accepted pills. Median age was 22 years, 71% were married; 89% were from MCH, and 11% were from FP clinics. Early PrEP use was positively influenced by encouragement from close confidants and effective concealment of PrEP pill-taking when necessary to avoid stigma or negative reactions from partners. Pregnancy helped conceal PrEP use because pill-taking is normalized during pregnancy, but concealment became more difficult postpartum. AGYW found keeping up with daily PrEP pill-taking challenging, and many noted only episodic periods of the HIV risk. Frequently testing HIV-negative reassured AGYW that PrEP was working and motivated persistence. DISCUSSION: As PrEP programs scale-up in MCH/FP, it is increasingly important to enhance protection-effective PrEP use through approaches tailored to AGYW, with special considerations during pregnancy and postpartum.
Authors: Christina Psaros; Jessica E Haberer; Elly Katabira; Allan Ronald; Elioda Tumwesigye; James D Campbell; Jonathan Wangisi; Kenneth Mugwanya; Alex Kintu; Michael Enyakoit; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Norma Ware; Jared M Baeten; Connie Celum; David R Bangsberg; Steve A Safren Journal: J Acquir Immune Defic Syndr Date: 2014-08-15 Impact factor: 3.731
Authors: Timothy R Muwonge; Kenneth Ngure; Elly Katabira; Nelly Mugo; Grace Kimemia; Bridget Frances O'Rourke Burns; Nicholas Musinguzi; Felix Bambia; Jared M Baeten; Renee Heffron; Jessica E Haberer Journal: AIDS Behav Date: 2019-05
Authors: Jillian Pintye; Kristin M Beima-Sofie; Pamela A Makabong'O; Anne Njoroge; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Connie Celum; Daniel Matemo; John Kinuthia; Maureen C Kelley; Grace C John-Stewart Journal: AIDS Patient Care STDS Date: 2018-07-23 Impact factor: 5.078
Authors: Michele R Decker; Elizabeth Miller; Heather L McCauley; Daniel J Tancredi; Heather Anderson; Rebecca R Levenson; Jay G Silverman Journal: Sex Transm Infect Date: 2013-11-14 Impact factor: 3.519
Authors: Jillian Pintye; John Kinuthia; D Allen Roberts; Anjuli D Wagner; Kenneth Mugwanya; Felix Abuna; Harison Lagat; George Owiti; Carol E Levin; Ruanne V Barnabas; Jared M Baeten; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2018-12-15 Impact factor: 3.731
Authors: Jessica E Haberer; Jared M Baeten; James Campbell; Jonathan Wangisi; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Christina Psaros; Steven A Safren; Norma C Ware; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Connie Celum; David R Bangsberg Journal: PLoS Med Date: 2013-09-10 Impact factor: 11.069
Authors: Dvora L Joseph Davey; Linda-Gail Bekker; Elizabeth A Bukusi; Benjamin H Chi; Sinead Delany-Moretlwe; Ameena Goga; Anne Drapkin Lyerly; Nyaradzo M Mgodi; Nelly Mugo; Landon Myer; Lisa M Noguchi; Lynda Stranix-Chibanda; Catherine Slack; Jillian Pintye Journal: Lancet HIV Date: 2022-01-25 Impact factor: 16.070
Authors: Alexandra M Minnis; Juliane Etima; Petina Musara; Erica N Browne; Prisca Mutero; Doreen Kemigisha; Nyaradzo M Mgodi; Clemensia Nakabiito; Mary Kate Shapley-Quinn; Marie C D Stoner; Miriam Hartmann; Nicole Macagna; Jeanna Piper; Ariane van der Straten Journal: AIDS Behav Date: 2022-06-08
Authors: Elizabeth E Tolley; Andres Martinez; Seth Zissette; Thesla Palanee-Phillips; Florence Mathebula; Siyanda Tenza; Miriam Hartmann; Elizabeth T Montgomery Journal: PLoS One Date: 2021-12-31 Impact factor: 3.240
Authors: Stephanie D Roche; Gena Barnabee; Victor Omollo; Felix Mogaka; Josephine Odoyo; Elizabeth A Bukusi; Jennifer F Morton; Rachel Johnson; Connie Celum; Jared M Baeten; Gabrielle O'Malley Journal: BMC Health Serv Res Date: 2022-03-30 Impact factor: 2.655
Authors: Lauren M Hill; Carol E Golin; Friday Saidi; Twambilile Phanga; Jennifer Tseka; Alinda Young; Lisa D Pearce; Suzanne Maman; Benjamin H Chi; Wilbroad Mutale Journal: J Int AIDS Soc Date: 2022-09 Impact factor: 6.707
Authors: Amelia M Stanton; Conall O'Cleirigh; Lucia Knight; Dvora L Joseph Davey; Landon Myer; John A Joska; Kenneth H Mayer; Linda-Gail Bekker; Christina Psaros Journal: J Int AIDS Soc Date: 2022-10 Impact factor: 6.707